
EU MDR/IVDR and UKCA pathways, FDA 510(k), De Novo and PMA strategy, SaMD classification, regulatory roadmapping, Notified Body and FDA engagement, and submission authoring.
ISO 13485 implementation, gap closure and scaling; ISO 14971 risk management; design controls and DHF/DTF; internal audits, supplier qualification and audit readiness.
Technical files and design dossiers, clinical evaluation plans and reports, verification & validation strategy, PMCF and PMS planning, vigilance and remediation support.